Antibiotics Market Globally at a rate of CAGR of 5.16% in the forecast period of 2021 to 2028

Market Analysis and Insights

·        An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used to treat and prevent such infections. They may either kill or inhibit the growth of bacteria.

·        The antibiotics are supportive and aim to destroy bacteria and cure infections. Data Bridge Market Research analyses that the antibiotics market will grow at a CAGR of 5.16% from 2022 to 2029. The “Hospital” segment dominates the end-user market.

Patient Epidemiology is a professional and complete report focusing on primary and secondary drivers, market share, competitor analysis, leading segments geographical analysis. This market research report has been structured by thoroughly comprehending the requirements of the business. Further, for an unequivocal and better understanding of facts and figures, the data is symbolized in the form of graphs, tables, and charts. The patient Epidemiology report gives a list of key competitors with the required specifications and also provides strategic insights and analysis of the key factors influencing the ABC industry.

With an exceptional Patient Epidemiology document, businesses can determine the range within which their products are to be offered to consumers. These market dynamics have the potential to impact Patient Epidemiology. Market insights of the report are helpful in determining the sizes, colcolorsesigns, prices, etc., of the products of the firm. Also, the defects in the existing product can be discovered and the required corrective steps to improve the product can be taken. The patient Epidemiology business report presents figures, graphs, and tables that will offer an extensive overview of the market.

Get a sample of the report

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-antibiotics-market

Patient Epidemiology Analysis

According to the United Nation's Ageing Population Report 2019, the global population aged 60 years or over was numbered 2 million in 2017, more than twice as large as in 1980 when there were 382 million older persons worldwide. In 2018, 447,694 diagnoses of sexually transmitted infections (STIs) were made in the United Kingdom, a 5% increase compared to 2017. Additionally, 56,259 diagnoses of gonorrhoea were reported in 2018, a 26% increase compared to 2017, and 7,541 diagnoses of syphilis were reported in 2018, a 5% increase compared to 2017

According to the WHO, in 2019, 10 million people were suffering from tuberculosis (TB) globally, and 1.4 million people died due to the disease.

Antibiotics market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Antibiotics Market

In addition, with the high need for the development of drugs and treatment for COVID-19, antibiotics are extensively being studied. For instance, in March 2020, Pfizer announced positive data for the use of its azithromycin (Zithromax) drug, along with hydroxychloroquine, in a coronavirus (COVID-19) clinical trial performed in France. Similarly, according to a study of 368 patients, in April 2020, there was no significant difference in mechanical ventilation risks in three cohorts of patients treated with hydroxychloroquine alone, a combo of hydroxychloroquine and azithromycin, and supportive care alone.

Recent Development

·        In October 2020, Pfizer Inc. announced the acquisition of Arixa Pharmaceuticals Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram-negative infections.

Global Antibiotics Market Scope

The antibiotics market is segmented on the basis of indication, drug class, and drug origin, spectrum of activity, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

·        Urinary tract infection

·        Intra-abdominal infections

·        Blood stream infections

·        Clostridium difficile infections

·        Others

On the basis of indication, the antibiotics market is segmented into urinary tract infection, intra-abdominal infections, blood stream infections, clostridium difficile infections and others.

Drug class

·        Beta lactam

·        Beta lactamase

·        Inhibitors

·        Quinolone

·        Macrolide

·        others

The drug class segment for antibiotics market includes beta lactam & beta lactamase inhibitors, quinolone, macrolide and others.

Drug origin

·        Natural

·        Semisynthetic

·        Synthetic

Spectrum of activity

·        Broad-spectrum antibiotic

·        Narrow-spectrum antibiotic

Antibiotics market is segmented into broad-spectrum antibiotic and narrow-spectrum antibiotic on the basis of spectrum of activity.

Route of Administration

·        Oral

·        Parenteral

·        Topical

·        Others

Route of administration segment of the antibiotics market is segmented into oral, parenteral, topical, and others.

End Use

·        Specialty Clinic

·        Hospital

·        Others

·        Homecare

Based on end-users, the antibiotics market is segmented into hospitals, homecare, specialty clinics, and others.

Distribution Channel

·        Hospital Pharmacy

·        Retail Pharmacy

·        Online Pharmacy

·        Others

The antibiotic market has also been segmented based on the distribution channel into hospital pharmacies, online pharmacies, and retail pharmacies.

Pipeline Analysis

In September 2020, Shionogi launched its new gram-negative antibiotic Fetcroja in the United Kingdom, which protects against all Gram-negative pathogens. In January 2020, Wockhardt received regulatory approval for its new antibiotics, EMROK (IV) and EMROK O (Oral), for the indication of acute bacterial skin and skin structure infections, including diabetic foot infections and concurrent bacteremia. The U.S. FDA granted Fast Track designations, Qualified Infectious Disease Product (QIDP) designation, and marketing exclusivity till 2028 for the product.

Antibiotics Market Regional Analysis/Insights

The antibiotics market is analyzed and market size insights and trends are provided by country, indication, drug class, and drug origin, the spectrum of activity, route of administration, end-users, and distribution channel as referenced above.

The countries covered in the antibiotics market report are the U.S., Canada, and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Antibiotics Market Share Analysis

The antibiotics market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the antibiotics market.

Some of the major players operating in the antibiotics market are Johnson & Johnson Services, Inc, Sanofi, Bayer AG, Abbott, F. Hoffmann-La Roche Ltd, Melinta Therapeutics, INC, Merck & Co., Inc., Allergan, Pfizer Inc, Novartis AG, LG Chem, Mylan N.V, Lupin, Hitech, Amneal Pharmaceuticals LLC, Zydus Cadila, Bausch Health, Teva Pharmaceutical Industries Ltd, Akron Incorporated, KYORIN Holdings, Inc, MerLion Pharmaceuticals GmbH and Wockhardt among others.

Get Full Access to the Report

https://www.databridgemarketresearch.com/reports/global-antibiotics-market

MAJOR TOC OF THE REPORT

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six: Antibiotics Market

Get TOC Details

https://www.databridgemarketresearch.com/toc/?dbmr=global-hemorrhoids-treatment-market

Browse Related Reports@

https://www.databridgemarketresearch.com/reports/global-macrolide-antibiotics-market

https://www.databridgemarketresearch.com/reports/global-feed-antibiotics-market

https://www.databridgemarketresearch.com/reports/global-peptide-antibiotics-market

https://www.databridgemarketresearch.com/reports/global-glycopeptide-antibiotics-market

https://www.databridgemarketresearch.com/reports/global-systemic-antibiotics-market

https://www.databridgemarketresearch.com/reports/global-inhaled-antibiotics-market

https://www.databridgemarketresearch.com/reports/global-animal-antimicrobials-and-antibiotics-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com